These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7460390)

  • 1. Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.
    Auer IO; Ziemer E; Sommer H
    Clin Exp Immunol; 1980 Oct; 42(1):41-9. PubMed ID: 7460390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect.
    Ginsburg CH; Dambrauskas JT; Ault KA; Falchuk ZM
    Gastroenterology; 1983 Oct; 85(4):846-51. PubMed ID: 6884709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural, lectin- and phorbol ester-induced cellular cytotoxicity in Crohn's disease and ulcerative colitis.
    Aparicio-Pagés MN; Verspaget HW; Peña AS; Weterman IT; Mieremet-Ooms MA; van der Zon JM; de Bruin PA; Lamers CB
    J Clin Lab Immunol; 1988 Nov; 27(3):109-13. PubMed ID: 3246686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.
    Aparició-Pagés MN; Verspaget HW; Peña AS; Weterman IT; de Bruin PA; Mieremet-Ooms MA; van der Zon JM; van Tol EA; Lamers CB
    J Clin Lab Immunol; 1989 Jul; 29(3):119-24. PubMed ID: 2517428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell activity in patients with inflammatory bowel disease.
    Egawa S; Hiwatashi N
    J Clin Lab Immunol; 1986 Aug; 20(4):187-92. PubMed ID: 3093683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological studies on Crohn's disease. III. Defective natural killer activity.
    Okabe N; Fujita K; Yao T
    J Clin Lab Immunol; 1985 Jul; 17(3):143-6. PubMed ID: 4046002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell function and lymphocyte subpopulation profiles in inflammatory bowel disease.
    Brown TE; Bankhurst AD; Strickland RG
    J Clin Lab Immunol; 1983 Jul; 11(3):113-7. PubMed ID: 6224936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Natural killer (NK) cells and interleukin 2 (IL-2) in Crohn disease].
    Lozano Polo JL; Echevarría Vierna S; Casafont Morencos F; Ledesma Castaño F; Pons Romero F
    Rev Esp Enferm Dig; 1990 Aug; 78(2):71-5. PubMed ID: 2271297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The cytotoxic activity in intestinal lamina propria and peripheral blood in AIDS and Crohn disease].
    Fink CO; Raedler A; Voss A
    Z Gastroenterol; 1996 Feb; 34(2):111-5. PubMed ID: 8659185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell and islet killer cell activities in human type 1 diabetes.
    Negishi K; Waldeck N; Chandy G; Buckingham B; Kershnar A; Fisher L; Gupta S; Charles AM
    Exp Clin Endocrinol; 1987 Aug; 89(3):345-53. PubMed ID: 3311777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appearance of killer (K) cells in the mesenteric lymph nodes in Crohn's disease.
    Britton S; Eklund AE; Bird AG
    Gastroenterology; 1978 Aug; 75(2):218-20. PubMed ID: 669207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune status in Crohn's disease. 4. In vitro antibody dependent cell mediated cytotoxicity in peripheral blood.
    Auer IO; Ziemer E
    Klin Wochenschr; 1980 Aug; 58(15):779-87. PubMed ID: 7442085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell activity in patients with multiple sclerosis given alpha interferon.
    Rice GP; Casali P; Merigan TC; Oldstone MB
    Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of blood donation on natural killer activity in man.
    Lasek W; Plodziszewska M; Jakobisiak M
    J Clin Lab Immunol; 1987 Apr; 22(4):165-8. PubMed ID: 3612753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of natural killer cell subsets (two color analysis) and their activity in peripheral blood in inflammatory bowel disease.
    Hirata I; Hayashi K; Asada S; Miyoshi H; Iwakoshi K; Ohshiba S
    Bull Osaka Med Coll; 1990 Nov; 36(1-2):47-55. PubMed ID: 2135644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological studies on Crohn's disease. IV. Decreased ADCC activity.
    Okabe N; Fujita K; Takenaka K; Yao T
    J Clin Lab Immunol; 1986 Feb; 19(2):77-81. PubMed ID: 3485720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients.
    Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL
    Thymus; 1997; 24(3):147-56. PubMed ID: 9151380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.